Home > Journals > Minerva Cardiology and Angiology > Past Issues > Minerva Cardioangiologica 2016 October;64(5) > Minerva Cardioangiologica 2016 October;64(5):552-9

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Cite this article as
Share

 

REVIEWS   

Minerva Cardioangiologica 2016 October;64(5):552-9

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

What’s up on sutureless valves

Giuseppe SANTARPINO, Jurij M KALISNIK, Theodor FISCHLEIN, Steffen PFEIFFER

Department of Cardiac Surgery, Klinikum Nürnberg, Paracelsus Medical University, Nuremberg, Germany


PDF


Sutureless aortic bioprostheses have been developed for use in high-risk patients undergoing surgical aortic valve replacement due to severe aortic stenosis. These devices are mounted on a stent and are self-anchoring within the aortic annulus with no need for sutures, resulting in shorter operative and, hence, ischemic times. The use of these devices makes therefore valve implantation easier and faster, which seems to improve postoperative outcomes. At present, there are two commercially available sutureless aortic valves: the Perceval S (LivaNova Group, Milan, Italy) and the Intuity (Edwards Lifesciences, Irvine, CA, USA). In this paper the studies published to date evaluating these two bioprosthesis models are reviewed, along with future directions and indications for the target patient population.

top of page